Recent studies revealed that ETV4 is aberrantly expressed in many types of tumors, and its overexpression is related to poor prognosis of cancer patients, including breast (10, 11), prostate (12), lung (13), and gastric (10, 14) cancers. Here, ETV4 is linked to cancer.